| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8537779 | Pulmonary Pharmacology & Therapeutics | 2018 | 26 Pages |
Abstract
Fluticasone/formoterol combination administered through a pMDI is as efficacious and well-tolerated as budesonide/formoterol and offers a new therapeutic option for patients with moderate to severe persistent asthma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Akash Balki, S. Balamurugan, Suhas Bardapurkar, Sonia Dalal, Ajeet Singh, B.P. Singh, Abhijit Vaidya, Jaideep A. Gogtay,